Fund shareholders of Tango Therapeutics Inc
ISIN US87583X1090 · United States
- Fund shareholders
- 166
- Of which ETFs
- 33 133 other funds
- Value held
- 455.2M $ 34.4M SEK
- Share of capital
- 13.9 % of 168.6M shares on Aug 4, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| PROFUND VP BIOTECHNOLOGY ProFunds | 10,787 | 225.7K $ | 0.54 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 10,120 | 218.8K $ | 0.03 % | 0.01 % | as of Apr 30, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 10,000 | 209.2K $ | 0.13 % | 0.01 % | as of Mar 31, 2026 ↗ |
| PD Small-Cap Value Index Portfolio PACIFIC SELECT FUND | 9,265 | 193.8K $ | 0.15 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Invesco Russell 2000 Dynamic Multifactor ETF Invesco Exchange-Traded Self-Indexed Fund Trust | 9,214 | 102.6K $ | 0.04 % | 0.01 % | as of Feb 28, 2026 ↗ |
| CVT Russell 2000 Small Cap Index Portfolio Calvert Variable Trust, Inc. | 9,089 | 190.1K $ | 0.08 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Nationwide Small Cap Index Fund Nationwide Mutual Funds | 8,941 | 193.3K $ | 0.07 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Gotham Absolute Return Fund FundVantage Trust | 8,551 | 178.9K $ | 0.02 % | 0.01 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 3000 INDEX FUND VANGUARD SCOTTSDALE FUNDS | 8,476 | 94.4K $ | 0.00 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Venerable Small Cap Index Fund Venerable Variable Insurance Trust | 8,086 | 169.2K $ | 0.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Small Cap Core Fund Northern Funds | 7,773 | 162.6K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Strategic Equity Allocation Trust John Hancock Variable Insurance Trust | 7,722 | 161.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 7,535 | 83.9K $ | 0.11 % | 0.00 % | as of Feb 28, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 7,222 | 156.1K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Voya VACS Index Series SC Portfolio Voya VARIABLE PORTFOLIOS INC | 6,863 | 143.6K $ | 0.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Small Cap Fund JNL Series Trust | 6,734 | 140.9K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 6,584 | 73.3K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 6,559 | 73.1K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| VIP Extended Market Index Portfolio Variable Insurance Products Fund II | 6,535 | 136.7K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 6,219 | 69.3K $ | 0.08 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Equity Market ETF Dimensional ETF Trust | 5,276 | 114.1K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Small-Cap Equity Portfolio PACIFIC SELECT FUND | 4,943 | 103.4K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| MFS Blended Research Small Cap Equity Portfolio MFS VARIABLE INSURANCE TRUST III | 4,767 | 99.7K $ | 0.13 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 4,610 | 51.4K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 4,533 | 94.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| AQR Small Cap Multi-Style Fund AQR Funds | 4,511 | 94.4K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Dimensional US Core Equity Market ETF Dimensional ETF Trust | 4,480 | 96.9K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 4,220 | 47K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 3,628 | 78.4K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 3,509 | 73.4K $ | 0.03 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Venerable US Small Cap Fund Venerable Variable Insurance Trust | 3,503 | 73.3K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| iShares Morningstar Small-Cap ETF iShares Trust | 3,411 | 73.7K $ | 0.03 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 3,100 | 64.9K $ | 0.08 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Vericimetry U.S. Small Cap Value Fund VERICIMETRY FUNDS | 2,940 | 61.5K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Longboard Fund NORTHERN LIGHTS FUND TRUST II | 2,915 | 32.5K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Gotham Enhanced Return Fund FundVantage Trust | 2,551 | 53.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 2,518 | 52.7K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 2,506 | 27.9K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 2,345 | 49.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Gotham Neutral Fund FundVantage Trust | 2,223 | 46.5K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 2,184 | 47.2K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 2,176 | 45.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Putnam Dynamic Asset Allocation Conservative Fund Putnam Asset Allocation Funds | 2,073 | 43.4K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Victory Cornerstone Aggressive Fund Victory Portfolios III | 1,646 | 18.3K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 1,251 | 27K $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Putnam Multi-Asset Income Fund Putnam Asset Allocation Funds | 1,243 | 13.8K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 1,233 | 25.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SA Franklin Allocation Moderately Aggressive Portfolio SEASONS SERIES TRUST | 1,042 | 21.8K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 933 | 19.5K $ | 0.10 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 925 | 20K $ | 0.13 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 905 | 18.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 779 | 16.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Putnam VT Global Asset Allocation Fund Putnam Variable Trust | 671 | 14K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 639 | 13.8K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Small Company Value Portfolio Wilshire Mutual Funds Inc | 610 | 12.8K $ | 0.06 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 528 | 11K $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 371 | 7.8K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 352 | 7.6K $ | 0.10 % | 0.00 % | as of Apr 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 281 | 5.9K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 243 | 5.1K $ | 0.04 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 203 | 4.4K $ | 0.06 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 145 | 3K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 109 | 1.2K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 79 | 1.7K $ | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 33 | 367.6 $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 28 | 585.8 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Invesco Dorsey Wright Healthcare Momentum ETF Invesco Exchange-Traded Fund Trust | 2.85 % | as of Apr 30, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 1.71 % | as of Apr 30, 2026 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 1.07 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 0.93 % | as of Apr 30, 2026 ↗ |
| HealthInvest Sustainable Healthcare Atle Fund Management AB | 0.74 % | as of Mar 31, 2026 ↗ |
| VOYA SMALL COMPANY PORTFOLIO Voya VARIABLE PORTFOLIOS INC | 0.68 % | as of Mar 31, 2026 ↗ |
| First Trust Small Cap Growth AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 0.58 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.56 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.54 % | as of Mar 31, 2026 ↗ |
| iShares Micro-Cap ETF iShares Trust | 0.48 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 164 | +36 | 23,192,673 | +5.3 % |
| 2026Q1 | 128 | -2 | 22,019,843 | +29.7 % |
| 2025Q4 | 130 | +17 | 16,978,884 | +28.1 % |
| 2025Q3 | 113 | -8 | 13,253,684 | +17.7 % |
| 2025Q2 | 121 | -7 | 11,256,626 | -0.7 % |
| 2025Q1 | 128 | -12 | 11,338,064 | -35.7 % |
| 2024Q4 | 140 | -6 | 17,627,156 | +5.9 % |
| 2024Q3 | 146 | -2 | 16,639,384 | -4.7 % |
| 2024Q2 | 148 | +16 | 17,458,796 | +36.0 % |
| 2024Q1 | 132 | +8 | 12,836,929 | +2.2 % |
| 2023Q4 | 124 | 12,560,347 |
Institutional managers
187 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| RTW INVESTMENTS, LP | 13,300,620 | 278.2M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 12,809,485 | 268M $ | as of Mar 31, 2026 |
| Boxer Capital Management, LLC | 10,876,219 | 227.5M $ | as of Mar 31, 2026 |
| TCG Crossover Management, LLC | 10,531,071 | 220.3M $ | as of Mar 31, 2026 |
| FMR LLC | 9,905,919 | 207.2M $ | as of Mar 31, 2026 |
| FARALLON CAPITAL MANAGEMENT LLC | 9,097,411 | 190.3M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 8,748,045 | 183M $ | as of Mar 31, 2026 |
| Woodline Partners LP | 8,000,013 | 167.4M $ | as of Mar 31, 2026 |
| Nextech Invest, Ltd. | 7,266,081 | 152M $ | as of Mar 31, 2026 |
| TRV GP IV, LLC | 6,374,574 | 133.4M $ | as of Mar 31, 2026 |
| Siren, L.L.C. | 5,657,105 | 118.3M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 5,076,392 | 106.2M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 4,651,894 | 97.3M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 4,146,813 | 86.8M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 4,009,679 | 83.9M $ | as of Mar 31, 2026 |
| Holocene Advisors, LP | 3,932,603 | 82.3M $ | as of Mar 31, 2026 |
| Balyasny Asset Management L.P. | 3,826,659 | 80.1M $ | as of Mar 31, 2026 |
| Logos Global Management LP | 3,000,000 | 62.8M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 2,750,000 | 57.5M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,675,777 | 56M $ | as of Mar 31, 2026 |
| Caligan Partners LP | 2,408,798 | 50.4M $ | as of Mar 31, 2026 |
| Bellevue Group AG | 2,400,000 | 50.2M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 2,394,972 | 50.1M $ | as of Mar 31, 2026 |
| Vivo Capital, LLC | 2,154,780 | 45.1M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,477,488 | 30.9M $ | as of Mar 31, 2026 |
Declared shareholders of Tango Therapeutics Inc
There are 8 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| RTW Investments, LP and 1 other | 9.30 % | 13,300,620 | as of Mar 31, 2026 · SCHEDULE 13G |
| Adage Capital Management, L.P. and 2 others | 8.98 % | 12,809,485 | as of Mar 31, 2026 · SCHEDULE 13G |
| TCG Crossover GP II, LLC and 2 others | 8.10 % | 11,597,737 | as of Mar 31, 2026 · SCHEDULE 13G |
| Farallon Capital Partners, L.P. and 27 others | 7.80 % | 11,257,203 | as of Mar 31, 2026 · SCHEDULE 13G |
| FMR LLC and 1 other | 6.90 % | 9,905,919 | as of Mar 31, 2026 · SCHEDULE 13G |
| Woodline Partners LP | 5.60 % | 8,000,013 | as of Mar 31, 2026 · SCHEDULE 13G |
| Nextech Crossover I GP S.a. r.l. and 4 others | 5.10 % | 7,266,081 | as of Mar 31, 2026 · SCHEDULE 13G |
| Invus Public Equities, L.P. and 7 others | 4.00 % | 5,657,105 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Tango Therapeutics Inc". https://titelia.com/en/stocks/tango-therapeutics-inc-US87583X1090